Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia

Table 1 Clinical outcomes of the ELGAN (n = 1508) study population as compared with the study sample (n = 54)

Outcome	ELGAN	Current cohort	P
Mortality	21%	11%	0.553
BPD	50%	37%	0.095
NEC (definite disease)	7%	7%	0.459
ROP	62%	48%	0.041
IVH	25%	23%	0.749
GA < 27 weeks	71%	52%	< 0.01

BPD, bronchopulmonary dysplasia; ELGAN, Extremely Low Gestational Age Newborn; NEC, Necrotizing Entercolitis (a serious infection of the bowel); IVH, Intraventricular Hemorrhage (bleeding in the brain); ROP, Retinopathy of Prematurity (a disease that affects immature vasculature in the eyes of premature babies causing significantly decreased vision); GA, Gestational Age.

ISSN: 1474-760X